期刊
NEUROBIOLOGY OF DISEASE
卷 35, 期 2, 页码 117-127出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.nbd.2009.04.010
关键词
Multiple sclerosis; Clinically isolated syndrome; Cerebrospinal fluid; Biomarker; Demyelination; Remyelination; Axonal damage; Glial activation; Blood-brain barrier; Blood-CSF barrier
资金
- Multiple Sclerosis Society [835] Funding Source: Medline
In patients with multiple sclerosis (MS) intensive efforts are directed at identifying biomarkers in bodily fluids related to underlying disease mechanisms, disease activity and progression, and therapeutic response. Besides MR imaging parameters cerebrospinal fluid (CSF) biomarkers provide important and specific information since changes in the CSF composition may reflect disease mechanisms inherent to MS. The different cellular and protein-analytical methods of the CSF and the recommended standard of the diagnostic CSF profile in MS are described. A brief update on possible CSF biomarkers that might reflect key pathological processes of MS such as inflammation, demyelination, neuroaxonal loss, gliosis and regeneration is provided. (C) 2009 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据